Navigation Links
FDA, NIH to Speak at CBI's 14th Annual Registries and Post-Approval Studies Congress
Date:8/18/2011

WOBURN, Mass., Aug. 18, 2011 /PRNewswire/ -- CBI is pleased to announce the full agenda for its industry-leading, 14th Annual Registries and Post-Approval Studies Congress, being held September 20-22, 2011 in Philadelphia, PA. The program, sponsored by REGISTRAT-MAPI, boasts an impressive speaker lineup from Celgene, Covidien, FDA, Forest, Ironwood Pharmaceuticals, Merck, NIH, Pfizer, Takeda Europe and many more.

Attendees have the opportunity to customize their congress experience by choosing between breakout sessions, concurrent tracks and participating in interactive panel discussions. Session highlights include:

  • Driving Value in Research by Designing, Implementing and Improving Patient Registries
  • Optimizing Post-Marketing Requirements and REMS
  • Developing Strategies to Benefit Sponsor and Regulatory Authorities
  • Complying with U.S., EU and Canadian Post-Approval Requirements
  • Responding to Increased Payer Requirements to Support Reimbursement Decisions
  • Maximizing the Value of Registries and Other Post-Approval Studies

Industry leaders will be afforded the exclusive opportunity to participate in the Invitation-Only Post-Approval Executive Summit hosted by REGISTRAT-MAPI. This 5th Annual Summit provides a unique forum for senior-level executives involved in post-approval studies, including clinical, medical, safety and regulatory to address the strategic issues they face.

CBI's Post-Approval Studies series is the industry's premier source for cutting-edge content and unparalleled programming related to post-approval studies. For more information on the conference or to view the entire agenda, please visit http://www.cbinet.com/postapproval.

About CBI:

CBI, a subsidiary of Advanstar, is the leading provider of market-driven, unbiased conferences for the pharmaceutical, biotechnology, medical device and healthcare industries. CBI offers specialized information presented in interactive formats by thought leaders and regulators. For more information, please visit http://www.cbinet.com.

About REGISTRAT-MAPI, Global Foundation Sponsor:

REGISTRAT-MAPI provides strategic and operational solutions for our clients in the design and implementation of Late Phase studies. REGISTRAT-MAPI is the pharmaceutical industry's largest global CRO dedicated exclusively to real-world clinical research. With more than 250 experienced professionals, REGISTRAT-MAPI has served the pharmaceutical and medical device industries for more than 20 years. For more information, please visit http://www.registratmapi.com.

For additional information or media inquiries, please contact Emily Forest, CBI Marketing Manager, at 339-298-2156 or Amy Wynn, REGISTRAT-MAPI Manager, Global Marketing, at 215-568-0121.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE CBI
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Accuray Incorporated to Speak at 2011 Wedbush Life Sciences: Management Access Conference
2. Pathogenica CSO Speaks at IBC Life Sciences Drug Discovery & Diagnostic Development Week
3. Qteros Management to Speak at June Conferences
4. CBI Keynote Speakers on Cover of Time Magazine
5. Verenium to Speak at the 2011 BIO World Congress on Industrial Biotechnology and Bioprocessing
6. Pam Marrone to Speak at Ag 2.0 Conference
7. Pharma ChemOutsourcing 2011 Unveils First Wave of 50 Biotech Chemist Speakers for September 12-15 Show in New Jersey
8. Science advisor to the US EPA to speak to industry, academic leaders on sustainability innovations
9. PRA International Expert to Speak at China Drug Safety Summit
10. Tianyins Dr. James Jiayuan Tong is Invited to Speak at the CFO China Summit 2011 on January 19, 2011 at the St. Regis Hotel, Beijing
11. Accuray Incorporated to Speak at Seventh Annual Lazard Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2016)... ... ... Ryan Benton was diagnosed with Duchenne Muscular Dystrophy (DMD) at the age ... DMD is a relatively common progressive genetic disorder, which causes aggressive deterioration of the ... He met with the founder of the Stem Cell Institute in Panama ...
(Date:5/17/2016)... , ... May 17, 2016 , ... ... and BioSmartSA, a healthcare consultancy based in Saudi Arabia, have formed a partnership ... to healthcare providers in the Kingdom of Saudi Arabia (KSA). , The ...
(Date:5/17/2016)... Switzerland , May 17, 2016 ... company located in Basel, Switzerland ... investigational oral inhibitor of P38 mitogen-activated protein kinase. ... , Strekin will build the necessary ... in indications in which MAP Kinases play fundamental ...
(Date:5/17/2016)... ... ... HOLLOWAY AMERICA, a stainless steel pressure vessel and tank manufacturing company, announced ... 19 in St. Louis, Missouri. The event will be held at the Hilton at ... during the early afternoon of the event, where the company’s representatives will be available ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):